David A. Siegel Ionis Pharmaceuticals Inc Put Options Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding IONS
# of Institutions
406Shares Held
148MCall Options Held
872KPut Options Held
432K-
Vanguard Group Inc Valley Forge, PA16.7MShares$688 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$661 Million0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$516 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$323 Million5.5% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...